Bloomberg News

Teva Second-Quarter Profit Rises 0.3%, Beating Analyst Estimates

July 27, 2011

July 27 (Bloomberg) -- Teva Pharmaceutical Industries Ltd.’s second-quarter profit rose 0.3 percent to $984 million, the company said today in a statement. Earnings per share were $1.10, beating the average analyst estimate of $1.08 per share.

To contact the editor responsible for this story: Naomi Kresge at

Monsanto vs. GMO Haters

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus